114 related articles for article (PubMed ID: 35659364)
1. Post COVID-19 condition and its physical, mental and social implications: protocol of a 2-year longitudinal cohort study in the Belgian adult population.
Smith P; Proesmans K; Van Cauteren D; Demarest S; Drieskens S; De Pauw R; Cornelissen L; De Ridder K; Charafeddine R
Arch Public Health; 2022 Jun; 80(1):151. PubMed ID: 35659364
[TBL] [Abstract][Full Text] [Related]
2. Anxiety and depression in people with post-COVID condition: a Belgian population-based cohort study three months after SARS-CoV-2 infection.
D'Hondt S; Gisle L; De Pauw R; Van Cauteren D; Demarest S; Drieskens S; Cornelissen L; De Ridder K; Charafeddine R; Smith P
Soc Psychiatry Psychiatr Epidemiol; 2024 May; ():. PubMed ID: 38819519
[TBL] [Abstract][Full Text] [Related]
3. Classification of post COVID-19 condition symptoms: a longitudinal study in the Belgian population.
Nayani S; Castanares-Zapatero D; De Pauw R; Van Cauteren D; Demarest S; Drieskens S; Cornelissen L; Devleesschauwer B; De Ridder K; Charafeddine R; Smith P
BMJ Open; 2023 Oct; 13(10):e072726. PubMed ID: 37802617
[TBL] [Abstract][Full Text] [Related]
4. Post COVID-19 condition and health-related quality of life: a longitudinal cohort study in the Belgian adult population.
Smith P; De Pauw R; Van Cauteren D; Demarest S; Drieskens S; Cornelissen L; Devleesschauwer B; De Ridder K; Charafeddine R
BMC Public Health; 2023 Jul; 23(1):1433. PubMed ID: 37495947
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
6. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
7. Design and recruitment of a large-scale cohort study on prevalence, risk factors and impact evaluation of post-COVID-19 condition and its wider long-term social, mental, and physical health impact: The PRIME post-COVID study.
Pagen DME; van Bilsen CJA; Brinkhues S; Moonen CPB; Van Herck M; Konings K; den Heijer CDJ; Mujakovic S; Ter Waarbeek HLG; Bouwmeester-Vincken N; Vaes AW; Spruit MA; Hoebe CJPA; Dukers-Muijrers NHTM
Front Public Health; 2022; 10():1032955. PubMed ID: 36589958
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Consequences of COVID-19 in Predominantly Immunonaive Patients: A Canadian Prospective Population-Based Study.
Benoit-Piau J; Tremblay K; Piché A; Dallaire F; Bélanger M; d'Entremont MA; Pasquier JC; Fortin M; Bourque C; Lapointe F; Betala-Belinga JF; Petit G; Jourdan G; Bahous R; Maya C; Benzina A; Faiyaz Hossain M; Peel MA; Houle O; Auger MS; Rioux A; Farand P
J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762880
[No Abstract] [Full Text] [Related]
9. Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study.
Wahlgren C; Forsberg G; Divanoglou A; Östholm Balkhed Å; Niward K; Berg S; Levi R
Lancet Reg Health Eur; 2023 May; 28():100595. PubMed ID: 36855599
[TBL] [Abstract][Full Text] [Related]
10. Cohort profile: Ngā Kawekawe o Mate Korona | Impacts of COVID-19 in Aotearoa - a prospective, national cohort study of people with COVID-19 in New Zealand.
Russell L; Jeffreys M; Churchward M; Cumming J; McKenzie F; O'Loughlin C; Asiasiga L; Bell R; Hickey H; Irurzun-Lopez M; Kamau L; Kokaua J; McDonald J; McFarland-Tautau M; Smiler K; Uia T; Vaka S; Veukiso-Ulugia A; Wong C; Ellison Loschmann L
BMJ Open; 2023 Jul; 13(7):e071083. PubMed ID: 37429685
[TBL] [Abstract][Full Text] [Related]
11. Persistent COVID-19 symptoms in community-living older adults from the Canadian Longitudinal Study on Aging (CLSA).
Griffith LE; Beauchamp M; McMillan J; Borhan S; Oz UE; Wolfson C; Kirkland S; Basta NE; Thompson M; Raina P;
Commun Med (Lond); 2023 Mar; 3(1):36. PubMed ID: 36906677
[TBL] [Abstract][Full Text] [Related]
12. Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland.
Baysson H; Pennachio F; Wisniak A; Zabella ME; Pullen N; Collombet P; Lorthe E; Joost S; Balavoine JF; Bachmann D; Azman A; Pittet D; Chappuis F; Kherad O; Kaiser L; Guessous I; Stringhini S;
BMJ Open; 2022 Jan; 12(1):e055515. PubMed ID: 35105645
[TBL] [Abstract][Full Text] [Related]
13. Long-term Consequences of COVID-19 and the Pandemic: Protocol for a Web-Based, Longitudinal Observational Study (DEFEAT).
Mikuteit M; Heinemann S; Roder S; Niewolik J; Schröder D; Vahldiek K; Klawitter S; Cossmann A; Bergemann T; Degen C; Klawonn F; Behrens GMN; Müller F; Dopfer-Jablonka A; Steffens S
JMIR Res Protoc; 2022 Oct; 11(10):e38718. PubMed ID: 36108134
[TBL] [Abstract][Full Text] [Related]
14. The need for holistic, longitudinal and comparable, real-time assessment of the emotional, behavioral and societal impact of the COVID-19 pandemic across nations.
Agorastos A; Tsamakis K; Solmi M; Correll CU; Bozikas VP
Psychiatriki; 2021 Apr; 32(1):15-18. PubMed ID: 33759804
[TBL] [Abstract][Full Text] [Related]
15. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
Hoşgelen EI; Alptekin K
Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34750798
[TBL] [Abstract][Full Text] [Related]
16. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
Hoşgelen EI; Alptekin K
Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34637131
[TBL] [Abstract][Full Text] [Related]
17. Rehabilitation Exercise and psycholoGical support After covid-19 InfectioN' (REGAIN): a structured summary of a study protocol for a randomised controlled trial.
McGregor G; Sandhu H; Bruce J; Sheehan B; McWilliams D; Yeung J; Jones C; Lara B; Smith J; Ji C; Fairbrother E; Ennis S; Heine P; Alleyne S; Guck J; Padfield E; Potter R; Mason J; Lall R; Seers K; Underwood M
Trials; 2021 Jan; 22(1):8. PubMed ID: 33407804
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
19. Supporting Parents & Kids Through Lockdown Experiences (SPARKLE): A digital parenting support app implemented in an ongoing general population cohort study during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial.
Kostyrka-Allchorne K; Creswell C; Byford S; Day C; Goldsmith K; Koch M; Gutierrez WM; Palmer M; Raw J; Robertson O; Shearer J; Shum A; Slovak P; Waite P; Sonuga-Barke EJS
Trials; 2021 Apr; 22(1):267. PubMed ID: 33838678
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
